Harrow Health Quote, Financials, Valuation and Earnings

Harrow Health Price Quote

+0.49 (+2.38%)
(Updated: March 30, 2023 at 11:50 PM ET)

Harrow Health Key Stats

Harrow Health (HROW) is a Buy

Day range:
$20.74 - $22.35
52-week range:
$5.40 - $22.35
Dividend yield:
P/E ratio:
P/S ratio:
P/B ratio:

Avg. volume:
1-year change:
Market cap:

How Much Does Harrow Health Make?

Is Harrow Health Growing As A Company?

  • What Is Harrow Health's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.01%
  • What Is Harrow Health's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

Harrow Health Stock Price Performance

  • Did Harrow Health Stock Go Up Last Month?
    Harrow Health share price went up by 16.04% last month
  • Did HROW's Share Price Rise Over The Last Year?
    HROW share price rose by 195.8% over the past 1 year

What Is Harrow Health 52-Week High & Low?

Harrow Health Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Harrow Health?

  • How Much Debt Does Harrow Health Have?
    Total long term debt quarterly is $104.2M
  • How Much Cash Does Harrow Health Have?
    Cash and short term investments quarterly total is $101.9M
  • What Is Harrow Health’s Book Value Per Share?
    Book value per share is 0.92

Is Harrow Health Cash Flow Positive?

  • What Is HROW Cash Flow From Operations?
    Cash flow from operations (TTM) is $1.7M
  • What Is Harrow Health’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $54.1M
  • What Is Harrow Health’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$1.7M

Harrow Health Return On Invested Capital

  • Is Management Doing A Good Job?
    HROW return on invested capital is -15.79%
  • What Is Harrow Health Return On Assets?
    ROA measures how assets are converting to revenues and is -12.8%
  • What Is HROW Return On Equity?
    ROE is a measure of profitability and is -125.91%

Harrow Health Earnings Date & Stock Price

Harrow Health Competitors

  • Who Are Harrow Health's Competitors?
    Below is a list of companies who compete with Harrow Health or are related in some way:
    • Ampio Pharmaceuticals Inc (AMPE)
    • iBio Inc (IBIO)
    • NovaBay Pharmaceuticals Inc (NBY)
    • Palatin Technologies Inc (PTN)
    • Theriva Biologics Inc (TOVX)

Harrow Health Dividend Yield

Data Unavailable

Harrow Health Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 0%
Revenue: 0.7% -6.45%

Analyst Recommendations

Buy Recommendations: 4
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 22.80
Upside from Last Price: 9.64%

Major Shareholders

  • How many HROW shares are owned by institutional investors?
    21.6M HROW shares are owned by institutional investors
  • How many HROW shares are owned by insiders?
    5.5M HROW shares are owned by insiders